PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 4, 20240 citations

Figure 1 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy

View Full Paper
EHElisabeth I. HeathGDGregory DysonJRJennifer R. Ribeiro

Key Points

Key points are not available for this paper at this time.

Abstract

Tumor lineages of the cohort and analysis of OS by race. A, Total numbers of each tumor type broken down by study site. B, Percentage of the total made up by each study site for the top 10 most represented tumor types. C, Kaplan–Meier curve for OS of White patients (black line) and Black patients (red line) among molecularly-tested cohort. D, COXPH analyzing the effect of race on OS in individual tumor types. *, P E and F, Median survival among the Caris cohort (E) or 5-year survival among the SEER cohort (F) was plotted for male and female White and non-White patients in three different age groups (

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Heath et al. (2024) studied this question.

synapsesocial.com/papers/68e55da7e2b3180350efabefhttps://doi.org/10.1158/2767-9764.27169598
Ask AI
Helpful
Bookmark
Share
View Full Paper